胸腹腔内窥镜手术系统
Search documents
马斯克预言三年机器人超人类医生 中国手术机器人产业已按下加速键?|科技观察
Sou Hu Cai Jing· 2026-01-13 14:44
封面新闻记者 边雪 近日,马斯克再次抛出"三年内机器人外科医生将全面超越人类"的惊人预言。当外界还在讨论AI能否辅助医生时,马斯克已将目光投向了完全替代。"AI 和机器人是'超音速海啸'(Supersonic Tsunami),我们已经身处'技术奇点'(Singularity)之中。" 马斯克预测,机器人不仅会进入工厂,更会进入手术室。"三到五年内,Optimus在手术台上的表现将超越最优秀的人类外科医生。"马斯克直言,机器人 的优势在于"极致的精准度"以及"共享的经验"。"每一个Optimus医生都能拥有全人类所有手术案例的经验总和。"他预言,到2040年,机器人的数量将达 到"100亿台甚至更多"。 但马斯克似乎没有注意到,在大洋彼岸的中国,一场以手术机器人为核心的医疗科技革命,早已不再是实验室里的蓝图。手术机器人的精确,来自精密制 造与人工智能(AI)的深度融合。成都博恩思医学机器人有限公司创始人CEO李耀表示:"AI能够实时分析医疗图像、手术数据,并理解医生的意图。在 传统手术中,医生判断病变位置,机器人通过智能算法和海量数据训练,可以更加精准地执行手术任务。" 机器人手术如何"走得更远"? 马斯克提 ...
智慧医疗照进现实 手术机器人焕然“医”新
Zheng Quan Ri Bao· 2025-05-23 15:50
Core Viewpoint - The surgical robotics industry in China is experiencing rapid growth and transformation, driven by advancements in technology such as smart algorithms and 5G, leading to increased market penetration and commercialization of surgical robots [1][3]. Industry Overview - The penetration rate of surgical robots in China has risen from 3.7% in 2020 to an expected 11.2% by 2025, with minimally invasive surgeries accounting for 68% of applications [1]. - The market size for surgical robots in China reached 71.7 billion yuan in 2023 and is projected to exceed 100 billion yuan by 2025, potentially surpassing 287 billion yuan by 2030 [3]. Technological Advancements - Surgical robots are becoming essential tools in clinical settings, enhancing precision and reducing recovery times for patients [2]. - The integration of 5G technology is enabling remote surgical operations, allowing surgeons to perform procedures from great distances, thus addressing regional disparities in healthcare access [8][10]. Domestic Development - The domestic production rate of surgical robots has exceeded 80%, with a significant increase in the number of approved products, indicating a shift from reliance on foreign technology to local innovation [1][4]. - By the end of 2024, 64 companies are expected to have a total of 115 surgical robot products approved, with domestic brands accounting for 81.7% of these approvals [4]. Market Dynamics - The Chinese market is characterized by a diverse ecosystem with multiple technological pathways and applications, unlike the more consolidated markets in Europe and the U.S. [7]. - Companies like MicroPort and Tianzhihang are making significant strides in both domestic and international markets, with products that have received approvals in multiple regions [7]. Future Outlook - The surgical robotics industry is anticipated to enter a phase of accelerated growth, particularly with the advent of remote surgical capabilities powered by 5G technology [9][10]. - The global market for remote surgical robots is expected to see explosive growth, with China emerging as the second-largest market after North America [9].